Loading clinical trials...
Loading clinical trials...
Arteriovenous Plasma Multiomics and Inflammatory Factors in Patients With Disorders of Consciousness
In order to determine the abnormal cerebral metabolism in the pathological state, we compared the blood of internal jugular vein, superior vena cava and radial artery during central venous catheterization. Metabonomics, proteomics and inflammatory factor microarray were used to detect the material differences in arteriovenous blood of patients with disorders of consciousness. At the same time, we concurrently compared it with the peripheral plasma metabolome of two additional patient cohorts: those in-stent restenosis and non-restenosis.
Background:It is unclear what substances the brain needs to ingest for its activity under pathological conditions Method:The uptake and release of substances by the brain were observed by comparing arterial blood with internal jugular vein blood;The characteristics of brain metabolites were observed by comparing internal jugular vein blood with superior vena cava blood. Compared it with the peripheral plasma metabolome of two additional patient cohorts: those in-stent restenosis and non-restenosis. Objective:By analyzing different substances, this paper briefly describes the pathological mechanism of patients with disorders of consciousness, and looks for potential prognostic biomarkers.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
The First Affiliated Hospital of Zhejiang University
Hanzhou, Zhejiang, China
Start Date
May 1, 2022
Primary Completion Date
March 30, 2024
Completion Date
April 30, 2024
Last Updated
May 7, 2024
100
ACTUAL participants
No intervention
OTHER
Lead Sponsor
First Affiliated Hospital of Zhejiang University
NCT06783049
NCT07143149
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions